期刊文献+

bFGF和Ets-1表达与原发性卵巢癌的关系 被引量:2

Expression of bFGF and Ets-1 in primary ovarian carcinoma ana vs significance
下载PDF
导出
摘要 目的检测碱性成纤维细胞因子(bFGF)和E26转录因子(Ets-1)在卵巢癌中的表达,为评估卵巢癌的生物学行为提供新的依据。方法应用免疫组织化学链霉素抗生物素—过氧化物酶复合法(SP)检测有2002年6月-2006年1月在哈医大二院病理科的50例卵巢癌组织中bFGF和Ets-1的表达,观察其与肿瘤组织学分级、临床分期、有无淋巴结转移及相互之间的关系。结果bFGF和Ets-1表达与原发性卵巢癌的FIGO分期、组织学分级密切相关(P<0.05);有大网膜淋巴结转移的病例bFGF和Ets-1阳性表达率显著高于无淋巴结转移的病例(P<0.05和P<0.05)。结论bF-GF和Ets-1的表达与原发性卵巢癌发生和转移有密切关系,检测bFGF和Ets-1的表达可作为了解卵巢癌生物学行为的参考指标。 Objective: To provide new evidence for understanding the biological behavior of primary ovarian carcinoma, the expression of basic fibroblast growth factor (bFGF) and E26 transformation - specific - 1 ( Ets - 1 ) was detected in primary ovarian carcinoma. Methods: Streptomycin avidin- biotin- peroxidase complex (SP) was used to detect the expression of bFGF and Ets -1 in 50 cases of primary ovarian carcinoma that come from the Second Affiliated Hospital of Harbin Medical University from June 2002 to January 2006 . The relationship between their expression and FIGO stage, histologic grade as well as the status of lymph node was analyzed. Results : ① Expression of bFGF and Ets - 1 closely correlated with FIGO stage and histologic grade of primary ovarian carcinoma. ② Within carcinoma tissue , patients with metastases of omental lymph - nodes had higher expression of bFGF and Ets - 1 than patients without metastases. Conclusion: The results show that the expression of bFGF and Ets - 1 primary ovarian carcinoma was involved in the bilological behavior.
出处 《中国优生与遗传杂志》 2007年第3期33-34,38,共3页 Chinese Journal of Birth Health & Heredity
关键词 原发性卵巢癌 碱性细胞成纤维因子 E26转录因子 免疫组织化学 Primary ovarian carcinoma Basic fibroblast growth factor E26 transformation - specific - 1 Immunohistochemistry
  • 相关文献

参考文献15

  • 1Davidson B, Risberg B, Goldberg B, et al. Ets - 1mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome[J]. Am J Surg Pathol, 2001,25(12) :1493 - 1500.
  • 2林卫,彭芝兰.碱性成纤维细胞生长因子在卵巢上皮性肿瘤中的表达及意义[J].中国修复重建外科杂志,1999,13(5):299-304. 被引量:26
  • 3Nakayama T, Ito M, Natiot S, et al. Expression of the Ets - 1 proto- oncogene in human colorectal carcinoma[ J ]. Mod Pathol, 2001,14(5) :415 -422.
  • 4Behrens P, Rothe M, Florin A, et al. lnvasive properties of serous human epithelial ovarian tumors are related to Ets - 1, MMP - 1 and MMP expression[J], Int J Mol Med, 2001,8(2) :149 - 154.
  • 5Herrem - Carlos - As, Xu Lei, et al. Expression of metastasis - related genes in human epithelial ovarian tumors[J]. Int J Oncol,2002, 20( 1 ) :5 - 13.
  • 6李晓梅,张友忠,江森.卵巢癌血管生成的临床研究进展[J].实用妇产科杂志,2001,17(2):78-80. 被引量:5
  • 7Wang Q Correlation between androgen regular expression and FGF8 mRNA levels in patient with prostate cancer and benign prostatie hypertrophy[J]. J Clin Pathol, 1999, 52:29 -34.
  • 8Nakayama T, et al. Expression of the Ets -1 proto - oncogene in human thyroid tumor[J]. Mod Pathol, 1999, 12:61 -68.
  • 9Cao Y, Therapeutic potentials of angiostatin in the treatment of cancer[J]. Haematologica, 1999,84(7) :643 -650.
  • 10Noel Weidner, Joseph P Seple, William R Welch, et al. Tumor Angiogenesis,324 : 1 - 7.

二级参考文献35

  • 1连利娟.林巧稚妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.780.
  • 2[1]Darai E,Bringuier AF,Walker CF,et al. CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: An immunohistochemicaland serological analysis. Gynecol Oncol, 1998,71(1) :122~127.
  • 3[2]Orre M,Miri LM, Mamers P,et al. Increased microvessle density in mucinous compareed with malignant serous and benign tumors of the ovary. Br J Cancer, 1998,77(12): 2204~2209.
  • 4[3]Orre M, Rogers PA. Reduced vascular basement-membrane immunostaining in mucinous tumors of the ovary. Int J Cancer, 1998,79(2) :139~143.
  • 5[4]Barton DP,Cai A,Wendt K,et al. Angiogenic protein expression in advanced epithelial ovarian cancer. 1997,3(9) : 1579~1586.
  • 6[5]Abulafia O, Triest WE, Sherer DM.Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Am J Obstet Gynecol.1997,133(3): 541~547.
  • 7[6]Gasparini G,Bonoldi E,Viale G,et al. Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas. Int J Cancer, 1996,69(3): 205~211.
  • 8[7]Orre M,Rogers PA. VEGF,VEGFR-1,VEGFR-2,microvessle density and endothelial cell proliferation in tumors of the ovary. Int J Cancer, 1999,84(2): 101 ~108.
  • 9[8]Carzetti GG,Ciavattini A,Lucarini G,et al. Expression of vascular endothelial growth factor related to 72-kolodalton metalloproteinase immunostaining in patients with serious ovarian carcinoma.Cancer, 1999,85 (10): 2219~2225.
  • 10[9]Fujimoto J,Sakaguchi H,Hirose R,et al. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer, 1999,83(12): 2528~ 2533.

共引文献28

同被引文献22

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部